Microencapsulated Charcoal Hemoperfusion for Galactosemia

  • P. Nasielski
  • T. M. S. Chang


In galactosemia, the elevation of galactose and subsequent metabolic products result in a variety of symptoms (1, 2) generally terminating in death. If this autosomal recessive enzyme deficiency is detected at birth diet restriction will alleviate the problem. However, for infants who have gone for weeks without a galactose-free diet, implementation of a restricted galactose diet has been of questionable benefit (3).


Activate Charcoal Artificial Cell Artificial Kidney Endogenous Intoxication Questionable Benefit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Woolf, L.I.: Inherited metabolic disorders: Galactosemia. Adv. Clin. Chem. 5:1, 1962, Academic Press, New York, N.Y.CrossRefGoogle Scholar
  2. 2.
    Hsia, D.-Y-Y.: Galactosemia. Charles C. Thomas, Publisher, Springfield, Illinois, 1969.Google Scholar
  3. 3.
    Shih, E.V., Levy, H.L., Karolkewiez, V., Houghton, S., Eflon, M.L., Isselbacher, K.J., Beutler, E., MacCready, R.A.: Galactose screening of newborns in Massachusetts. New Eng. J. Med. 284, #14:753, 1971.PubMedCrossRefGoogle Scholar
  4. 4.
    Yatzidis, H.: A convenient hemoperfusion micro-apparatus over charcoal for the treatment of endogenous Intoxications. Proc. Europ. Dialysis Transplant. Assoc. 1:83, 1964.Google Scholar
  5. 5.
    Chang, T.M.S.: Semipermeable microcapsules. Science 146: 524, 1964.PubMedCrossRefGoogle Scholar
  6. 6.
    Chang, T.M.S.: Semipermeable aqueous microcapsules (artificial cells) with emphasis on experiments in an extracorporeal shunt system. Trans. Amer. Soc. Artif. Intern, Organs 12:13, 1966.Google Scholar
  7. 7.
    Chang, T.M.S.: “Artificial Cells”, Charles C. Thomas, Publisher, Springfield, Illinois, 1972.Google Scholar
  8. 8.
    Chang, T.M.S.: Removal of endogenous and exogenous toxins by a microencapsulated adsorbent. Canad. J, Physiol. Pharmacol. 47:1043, 1969.CrossRefGoogle Scholar
  9. 9.
    Chang, T.M.S.: Microencap. adsorbent hemoperfusion for uremia intoxication and hepatic failure. Kidney International 7:S387, 1975.Google Scholar
  10. 10.
    Chang, T.M.S.: Microcapsule artificial kidney: including updated preparative procedures and properties. Kidney Int. 10:S218, 1976.Google Scholar
  11. 11.
    Nasielski, P.: Galactose removal by microencapsulated adsorbent, M.Sc. Thesis, Physiology, McGill University, Montreal.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • P. Nasielski
    • 1
  • T. M. S. Chang
    • 1
  1. 1.Artificial Organs Research Unit, Departments of Physiology and MedicineMcGill UniversityMontrealCanada

Personalised recommendations